PCOS NuvaRing Study

 

The Penn PCOS Center is conducting a clinical study to compare the effects of NuvaRing on metabolic risk factors such as weight, blood pressure, glucose, and cholesterol levels in overweight/obese women with Polycystic Ovary Syndrome (PCOS) over a four-month period.  You will be asked to use the NuvaRing for four consecutive months during the treatment period.

​

Your participation in this study will consist of a screening and enrollment visit, a completion visit, along with once-monthly email check-ins.  There is a possibility that screening and enrollment into the study will take place during separate visits.  During this time, you will receive laboratory assessments including blood draws, medical history review, questionnaires, and compensation.  Your participation in this study will not have any direct benefit to you or your routine medical care.

​

Women with a diagnosis of PCOS, between the ages of 18 and 40, with a BMI score of >=25 and =<42, no metabolic syndrome, and not seeking pregnancy may be eligible to participate.

​

If you are interested in seeing if you qualify for this study, click here or call 215.662.7727.

 

Principal Investigator:

Andrea Roe, MD, MPH

​

Research Coordinator:

Andrea Morley

​